Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsa Sousa

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Seminars in Arthritis and Rheumatism|February 21, 2026
Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study): effect of regulatory warningsDenis Mongin, Romain Aymon, Denis Choquette, et al.
Arthritis Research & Therapy|April 6, 2007
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoterJoão Eurico Fonseca, João Cavaleiro, José Teles, et al.
Acta Reumatologica Portuguesa|September 4, 2009
[Practical guide for the use of biotechnological therapies in rheumatoid arthritis]João Eurico Fonseca, J A Canas Silva, Helena Canhão, et al.
Acta Reumatologica Portuguesa|April 5, 2012
[Practical guide for the use of biological agents in rheumatoid arthritis - December 2011 update]Ana Filipa Mourão, João Eurico Fonseca, Helena Canhão, et al.
Acta Reumatologica Portuguesa|April 5, 2012
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 updateJoão Eurico Fonseca, Miguel Bernardes, Helena Canhão, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Seminars in Arthritis and Rheumatism|February 21, 2026
Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study): effect of regulatory warningsDenis Mongin, Romain Aymon, Denis Choquette, et al.
Arthritis Research & Therapy|April 6, 2007
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoterJoão Eurico Fonseca, João Cavaleiro, José Teles, et al.
Acta Reumatologica Portuguesa|September 4, 2009
[Practical guide for the use of biotechnological therapies in rheumatoid arthritis]João Eurico Fonseca, J A Canas Silva, Helena Canhão, et al.
Acta Reumatologica Portuguesa|April 5, 2012
[Practical guide for the use of biological agents in rheumatoid arthritis - December 2011 update]Ana Filipa Mourão, João Eurico Fonseca, Helena Canhão, et al.
Acta Reumatologica Portuguesa|April 5, 2012
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 updateJoão Eurico Fonseca, Miguel Bernardes, Helena Canhão, et al.
Pageof 2